CEL SCI Cash Per Share vs. Current Valuation
| CVM Stock | USD 0.65 0.04 5.80% |
Cash Per Share | First Reported 2010-12-31 | Previous Quarter 0.11 | Current Value 0.1 | Quarterly Volatility 3.32726915 |
For CEL SCI profitability analysis, we use financial ratios and fundamental drivers that measure the ability of CEL SCI to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well CEL SCI Corp utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between CEL SCI's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of CEL SCI Corp over time as well as its relative position and ranking within its peers.
CEL |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CEL SCI. If investors know CEL will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CEL SCI listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.52) | Revenue Per Share 0.001 | Quarterly Revenue Growth (0.63) | Return On Assets (0.61) | Return On Equity (2.50) |
The market value of CEL SCI Corp is measured differently than its book value, which is the value of CEL that is recorded on the company's balance sheet. Investors also form their own opinion of CEL SCI's value that differs from its market value or its book value, called intrinsic value, which is CEL SCI's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CEL SCI's market value can be influenced by many factors that don't directly affect CEL SCI's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CEL SCI's value and its price as these two are different measures arrived at by different means. Investors typically determine if CEL SCI is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CEL SCI's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
CEL SCI Corp Current Valuation vs. Cash Per Share Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining CEL SCI's current stock value. Our valuation model uses many indicators to compare CEL SCI value to that of its competitors to determine the firm's financial worth. CEL SCI Corp is rated fifth in cash per share category among its peers. It is rated fourth in current valuation category among its peers reporting about 85,806,823 of Current Valuation per Cash Per Share. At this time, CEL SCI's Cash Per Share is very stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value CEL SCI by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.CEL Current Valuation vs. Cash Per Share
Cash per Share is a ratio of current cash on hands or in the banks of the company to a total number of shares outstanding. It is used to determine a firm's liquidity and is a good indicator of the overall financial health of a company. Value investors often compare this ratio to the current stock quote, and if it exceeds the stock price they would invest in it.
CEL SCI |
| = | 0.65 X |
Companies with high Cash per Share ratio will be considered as an attractive investment by most investors. In most industries if you can single out an equity instrument trading below its cash per share value, you have a bargain and should consider buying it. Finding the stocks traded below their cash value, therefore, can be a good starting point for investors using strategies based on fundamentals.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
CEL SCI |
| = | 55.77 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
CEL Current Valuation vs Competition
CEL SCI Corp is rated fourth in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 3.47 Billion. CEL SCI claims roughly 55.77 Million in current valuation contributing just under 2% to equities under Health Care industry.
CEL SCI Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in CEL SCI, profitability is also one of the essential criteria for including it into their portfolios because, without profit, CEL SCI will eventually generate negative long term returns. The profitability progress is the general direction of CEL SCI's change in net profit over the period of time. It can combine multiple indicators of CEL SCI, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Operating Income | -28.3 M | -26.9 M | |
| Net Loss | -29 M | -27.5 M | |
| Income Tax Expense | 569.3 K | 597.8 K | |
| Income Before Tax | -29 M | -27.5 M | |
| Total Other Income Expense Net | -826 K | -784.7 K | |
| Net Loss | -33.9 M | -35.6 M | |
| Net Loss | -29 M | -30.4 M | |
| Non Operating Income Net Other | 398.8 K | 378.9 K | |
| Interest Income | 642.8 K | 610.7 K | |
| Net Interest Income | -776.7 K | -815.6 K | |
| Change To Netincome | 13.6 M | 14.3 M | |
| Net Loss | (0.65) | (0.69) | |
| Income Quality | 0.82 | 0.83 | |
| Net Income Per E B T | 0.90 | 0.83 |
CEL Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on CEL SCI. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of CEL SCI position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the CEL SCI's important profitability drivers and their relationship over time.
Use CEL SCI in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if CEL SCI position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CEL SCI will appreciate offsetting losses from the drop in the long position's value.CEL SCI Pair Trading
CEL SCI Corp Pair Trading Analysis
The ability to find closely correlated positions to CEL SCI could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace CEL SCI when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back CEL SCI - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling CEL SCI Corp to buy it.
The correlation of CEL SCI is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as CEL SCI moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if CEL SCI Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for CEL SCI can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your CEL SCI position
In addition to having CEL SCI in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Health Care ETFs Thematic Idea Now
Health Care ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Health Care ETFs theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Health Care ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Check out Trending Equities. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
To fully project CEL SCI's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of CEL SCI Corp at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include CEL SCI's income statement, its balance sheet, and the statement of cash flows.